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Fetal life elapses in a relatively low oxygen environment. Immediately after birth with the 
initiation of breathing, the lung expands and oxygen availability to tissue rises by twofold, 
generating a physiologic oxidative stress. However, both lung anatomy and function and 
the antioxidant defense system do not mature until late in gestation, and therefore, very 
preterm infants often need respiratory support and oxygen supplementation in the deliv-
ery room to achieve postnatal stabilization. Notably, interventions in the first minutes of 
life can have long-lasting consequences. Recent trials have aimed to assess what initial 
inspiratory fraction of oxygen and what oxygen targets during this transitional period are 
best for extremely preterm infants based on the available nomogram. However, oxygen 
saturation nomogram informs only of term and late preterm infants but not on extremely 
preterm infants. Therefore, the solution to this conundrum may still have to wait before a 
satisfactory answer is available.
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iNTRODUCTiON
Good and evil we know in the field of this world grow up together almost inseparably.
Paradise Lost (John Milton; 1608–1674)
Adaptation to extra uterine life implies major cardiovascular and respiratory changes that occur in 
a timely fashion along the first few minutes after birth. Placental gas exchange is substituted by air-
borne lung respiration. The initial breathing movements yield an increment of the oxygen content in 
arterial blood. Hence, partial pressure of oxygen (paO2) increases from 3.3 kPa (25–30 mmHg) in the 
fetus to 10.5 kPa (75–85 mmHg) in the newly born only 5 min after cord blood circulation ceases. 
Increased paO2 elicits the dilatation of the pulmonary vascular bed, reduction of pulmonary vascular 
resistance, enhances pulmonary blood flow, left heart preload, and closure of intra- and extracardiac 
shunts (1). An adequate oxygenation is indispensable not only for providing the energy required for 
the normal functionality of oxy-regulator tissues, such as heart and brain, but also for growth and 
development of the newborn infant.
FiGURe 1 | Acetyl-coA is the merging metabolite derived from basic nutrients. Entering into the inner mitochondrial space acetyl-coA will undergo a 
metabolic transformation in the tricarboxylic cycle (Kreb’s cycle). During this process, highly energized electrons are liberated and transported by specific electron 
transporters to the electron transport chain (ETC). Energy is used to extrude protons and thus establish a transmembrane potential (Ψm). In the final step, ATP 
synthase will again intrude protons in the inner mitochondrial space. The energy provided by Ψm will be employed to synthesize adenosine triphosphate (ATP) from 
adenosin diphosphate (ADP). Oxygen will be reduced with four electrons and combined with two protons to form water. This process is known as oxidative 
phosphorylation.
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This extraordinary ensemble of timely and synchronized 
physiological responses requires the maturity of the cardiovas-
cular, the respiratory, and the antioxidant (AO) defense systems.
The present review will focus on the fundamental physiologic 
role of oxygen during the fetal to neonatal transition and the dif-
ficulties to translate our yet imprecise and incomplete knowledge 
of oxygen metabolism into clinical protocols that regulate oxygen 
supplementation, especially to preterm infants, to avoid the del-
eterious consequences derived from a lack or an excess of oxygen.
OXYGeN AND OXiDATive STReSS
Aerobic Metabolism and Oxygen 
Physiology
Oxygen (O2) is indispensable for the provision of sufficient 
energy to allow multicellular organisms an adequate growth and 
development. Nutritional components, such as carbohydrates, 
fat, and proteins, are converted during digestion in simple mol-
ecules, such as glucose, fatty acids, or amino acids. Combustion of 
these nutritional elements in the mitochondria in the presence of 
oxygen occurs in a two-step process known as oxidative phospho-
rylation (Figure 1). The energy balance derived from oxidative 
phosphorylation is substantially more efficient than in anaerobic 
metabolism. Hence, while 1 mol of glucose generates a positive 
balance of 2 mol of adenosine triphosphate (ATP) under anaero-
bic conditions, in the presence of O2, it will generate 32–36 mol 
of ATP. Thus, the energy efficiency of aerobic is 16–18 times that 
of anaerobic metabolism (2).
O2 is present in nature generally as ground molecular di-
oxygen. To achieve conformational stability, O2 needs to be 
reduced by four electrons. Paramagnetic properties confer O2 
with a low reactivity, and therefore, to establish bonds with other 
FiGURe 2 | Oxygen (1) is stepwise reduced by just one electron 
leading to the formation of anion superoxide (2). Anion superoxide is 
dismutated by superoxide dismutases (SODs) to hydrogen peroxide (3), 
which in turn is transformed into water and oxygen by the action of catalases 
(CATs) and glutathione peroxidase (GPX). In the presence of transition metals 
(e.g., iron and copper), hydrogen peroxide can be transformed into hydroxyl 
radical (4). Moreover, in the presence of nitric oxide (NO), anion superoxide 
can also be transformed into peroxynitrite (5). Anion superoxide, hydroxyl 
radical, and peroxynitrite are highly reactive free radicals that will cause 
structural and functional damage to nearby standing molecules. Hydrogen 
peroxide will act as a cell-signaling molecule. Reduced glutathione (GSH) is 
the most relevant non-enzymatic antioxidant in the cell cytoplasm and an 
essential determinant of cell’s redox balance.
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compounds oxygen, it will undergo a step-by-step tetravalent 
reduction. However, incomplete reduction with just one electron 
at a time will lead to the formation of intermediate reactive 
oxygen species (ROS), such as anion superoxide (O2−), hydrogen 
peroxide (H2O2), or hydroxyl radical (OH⋅) (Figure 2).
Superoxide and hydroxyl radical both are free radicals. Free 
radicals are atomic or molecular species capable of independent 
existence that contain one or more unpaired electrons in their 
molecular orbitals. They are able, therefore, to oxidize cellular 
membranes, structural and functional proteins, and nucleic acids. 
In the presence of nitric oxide (⋅NO), oxygen-derived free radi-
cals will react forming reactive nitrogen species (RNS) such as 
peroxynitrite (ONOO−). ROS and RNS are potent oxidizing and 
reducing agents that subtract electrons from any nearby standing 
molecules altering their structure and function, and begetting 
them into free radicals (2–4).
In recent years, the concept of the redox code has been 
postulated. The redox code consists of four principles by which 
biological systems are organized being O2 central to all of them. 
These include electron donating and accepting properties of 
nicotinamide adenine dinucleotide (NAD) and NAD phosphate 
(NADP) linked to ATP production and catabolism; protein ter-
tiary structure conformation through kinetically controlled redox 
switches that regulate interactions, trafficking activity, etc.; the role 
of hydrogen peroxide in redox-sensing mechanisms; and finally 
the ability of redox networks to conform to an adaptive system 
that responds to the environment (5). Interestingly, the response 
to the environment is performed through subcellular systems 
from microcompartments (cytoplasm, endoplasmic reticulum, 
nucleus, and extracellular space) that have an individual and 
characteristic redox potential that can be altered individually 
without a concomitant alteration of the other tissue territories. 
As a consequence, the older concept of oxidative stress as a global 
situation affecting the entire economy is under review (6, 7).
Antioxidant Defenses
To overcome the deleterious actions of oxygen free radicals, AO 
defense systems have evolved (Figure 2). AO defenses can be enzy-
matic and non-enzymatic in nature. The families of superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), 
and glucose 6-phosphate dehydrogenase (G6PD) represent, from 
a clinical perspective, the most relevant AO enzymes. In addition, 
there are a series of compounds capable of neutralizing ROS and 
free radicals. The most abundant cytoplasmic non-enzymatic 
AO is glutathione (GSH), a ubiquitous tripeptide formed by 
γ-glutamine, l-cysteine, and glycine. GSH easily combines with 
another GSH resulting in GSSG (oxidized glutathione), thus 
providing two electrons, which are used to satisfy the promiscu-
ous appetite of free radicals. GSSG is reduced again to GSH by 
glutathione reductase (GSH-reductase) with the electrons coming 
from the Krebs cycle and provided by NADPH (reduced form 
of NADP) (Figure  2). Other relevant non-enzymatic AO are 
proteins that bind transition metals, such as transferrin and ceru-
loplasmin, or molecules that quench free radicals, such as uric 
acid and bilirubin, and certain vitamins, such as A, E, and C (2).
Oxidative stress refers to the disequilibrium that ensues in an 
organism when the formation of free radicals overrides the ability 
of biologic system to completely neutralize them. Oxidative stress 
can be physiologic in nature (oxidative eustress) and necessary to 
activate specific metabolic pathways or pathologic (oxidative dis-
tress), which causes damage to structures and alters the function 
of biological systems. Oxidative stress can result from diminished 
AO levels or AO enzymes’ response capacity, or defects in the 
genes that regulate the AO machinery. In addition, oxidative 
stress may also be the consequence of an increased supplementa-
tion with O2, toxic substances, radiation, etc. (2–4).
Enzymatic and non-enzymatic AO defenses mature late in 
gestation. Therefore, preterm infants, especially those who are 
very preterm (≤28 weeks GA), are endowed with an immature 
AO defense system that is characterized by a diminished capacity 
of response to a pro-oxidant aggression (8). In addition, preterm 
infants are depleted of non-enzymatic AO, such as vitamins 
(E, D, C, flavonoids, and carotenoids), or micronutrients (sele-
nium, copper, zinc, etc.) that accumulate in the fetus at the end 
of gestation (9).
Biomarkers employed to evaluate oxidative stress may directly 
reflect a pro- or anti-oxidant status (redox status) such as GSH/
GSSG ratio. Furthermore, the may inform on damage to the cell 
components, such as lipids (malondialdehyde or n-aldehydes), 
nucleic acids [8-oxo-deyhydroguanosine (8-oxodG)], or proteins 
(oxidized tyrosine and carbonyl compounds) (2). In recent years, 
isoprostanes and isofurans have evolved as one of the most reli-
able markers of oxidative stress assessing peroxidation of poly-
unsaturated fatty acids (PUFA) (Table 1) (10, 11).
TABLe 1 | Oxidative stress and damage biomarkers used in the clinical setting and in human research, targeted biofluids, and recommended analytical 
techniques.
Oxidative biomarkers Target biomolecule Modification Biological sampling Analytical method
Glutathione (GSH/GSSG ratio) Antioxidants General redox status Total blood LC–MS/MS
MDA Lipids PUFA peroxidation Plasma HPLC (UV detection)
HNE Lipids PUFA peroxidation Plasma HPLC
o-Tyrosine (o-Tyr/Phe ratio) Proteins Tyrosine hydroxylation Urine LC–MS/MS
m-Tyrosine (m-Tyr/Phe ratio) Proteins Tyrosine hydroxylation Urine LC–MS/MS
3N2-tyrosine Proteins Tyrosine nitratation Urine LC–MS/MS
8OHdG (8OHdG/2dG ratio) Lipids AA peroxidation Urine/plasma LC–MS/MS
F2-IsoPs Lipids AA peroxidation Urine/plasma GC–MS/MS; LC–MS/MS
D2/F2-ISoPs Lipids AA peroxidation Urine/plasma GC–MS/MS; LC–MS/MS
IsoFs Lipids AA peroxidation Urine/plasma GC–MS/MS; LC–MS/MS
NeuPs Lipids DHA peroxidation Urine/plasma GC–MS/MS; LC–MS/MS
NeuFs Lipids DHA peroxidation Urine/plasma GC–MS/MS; LC–MS/MS
Modified from Vento et al. (2).
GSH, reduced glutathione; GSSG, oxidized glutathione; MDA, malondialdehyde; HNE, 4-hydrox-2-non-enal; o-Tyr, ortho-tyrosine; m-Tyr, meta-tyrosine; 3N2-Tyrosine, 
3-nitrotyrosine; 8OHdG, 8-hydroxi-2′-deoxiguanosine; 2dG, 2′-deoxiguanosine; IsoPs, isoprostanes; IsoFs, isofurans; NeuPs, neuroprostanes; NeuFs, neurofurans; AA, arachidonic 
acid; DHA, docosahexaenoic acid; LC, liquid chromatography; GC, gas chromatography; MS/MS, tandem mass spectrometry.
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Reactive oxygen species and RNS also trigger proinflamma-
tory responses in the cells promoting the activation of nuclear 
factor-kappa B (NF-κB), a transcription factor for multiple 
inflammation-related genes, and tumor necrosis factor alpha 
(TNFα), crucial in the inflammatory response as well as in the 
activation of apoptosis (12). ROS act upon redox mechanisms, 
which control gene expression, cell proliferation, and apoptosis. 
Diffusible H2O2 especially, but also other ROS, act reversibly 
oxidizing and reducing signaling proteins, providing a means for 
control of protein activity, protein–protein interaction, protein 
trafficking, and protein–DNA interaction (5, 9).
Maturation of the Antioxidant System
In experimental studies, it has been documented that AO enzyme 
levels in the lung of different mammals are not expressed until 
late in gestation. The timing of development of both fetal lung 
AO enzymes (SOD, CAT, and GPX) and surfactant followed 
a similar pattern of prenatal biochemical maturation. Hence, 
during the final 10–15% of gestation, there was an exponential 
increase of 150–200% activity in the AO enzymes present in 
lung tissue. Moreover, simultaneously, there was an essentially 
parallel rapid rise in lung surfactant content. Both these devel-
opmental changes suggest a preparation to facilitate the estab-
lishment of an effective alveolar recruitment and gas exchange 
after birth (13, 14). Consequently, preterm infants with an 
immature AO enzyme system will be predisposed to oxidative 
stress-associated lung damage. Notably, the use of antenatal 
steroids increases the AO enzyme activity, especially in preterm 
females improving their ability to satisfactorily transit into the 
extra uterine world (8).
Resistance to oxidative stress also relies on non-enzymatic 
AOs, such as vitamins (A, E, and C), and compounds, such as 
glutathione, peroxiredoxin, or thioredoxin. Significantly higher 
levels of vitamins A, E, and C have been found in term as compared 
to preterm infants (9). However, supplementation with ascorbic 
acid and tocopherol to baboons submitted to a hyperoxia did not 
effectively offset oxidative stress-derived lung damage (15).
The GSH/GSSG ratio is considered one of the most reliable 
markers of cellular reducing state (16). Notably, the physiologic 
oxidative stress inherent to fetal to neonatal transition favors the 
upregulation of specific enzymes, such as γ-cystathionase in the 
trans-sulfuration pathway, which is the limiting enzyme that 
facilitates l-cysteine synthesis and thus glutathione synthesis 
(17). Remarkably, γ-cystathionase is also expressed late in gesta-
tion, and therefore, l-cysteine renders an indispensable amino 
acid in very preterm infants. Moreover, synthesis of GSH below 
32 weeks gestation is significantly lower than in late preterm or 
term infants predisposing these babies to an increased oxidative 
stress in the fetal to neonatal transition (18).
OXYGeN iN FeTAL LiFe
Fetal Oxygen environment
Fetal life develops in an environment relatively hypoxic, when 
compared to the extra uterine; hence, in utero paO2 is ≈3.5–4.5 kPa 
(25–35 mmHg) while in adults is ≈11.5–13.0 kPa (80–90 mmHg) 
(1). However, in spite of this, fetal tissues receive an oxygen load 
that does not substantially differ from the newborn or adult. 
The presence of fetal hemoglobin with a greater affinity for 
oxygen enhances oxygen uptake from the intervillous space 
by fetal erythrocytes. As a consequence, fetuses have increased 
oxygen saturation (SpO2) for a given paO2 as compared to adults. 
Furthermore, the fetal cardiac output is extremely high reaching 
values of 250–300  mL/kg/min, thus providing tissue with an 
adequate flow rate in spite of lower oxygen content. Moreover, 
venous return from the placenta is directed to the most oxygen 
demanding organs, such as heart and central nervous system, 
through extra- and intracardiac shunting (19).
Oxygenation of the fetus is clearly dependent on the partial 
pressure gradients between maternal blood, placental tissue, fetal 
blood, and tissue. Remarkably, the level of placental oxygen, as 
measured in the intervillous space, differs at different stages of 
gestation (Figure 3). The provision of an adequate amount of oxy-
gen to the fetus shifts along gestation. Hence, levels considered 
FiGURe 3 | Oxygenation of the fetus is clearly dependent on the 
partial pressure gradients between maternal blood, placental tissue, 
fetal blood, and tissue. The level of intervillous oxygen concentration varies 
along gestation. Studies performed in human fetuses have shown that before 
the 12th week of gestation, the intervillous partial pressure of oxygen (PIVO2) 
has a median value around 18–20 mmHg, presumably to protect the embryo, 
which is highly sensitive to ROS. However, PIVO2 rises in the following weeks 
reaching a peak value (60 mmHg) around 14–16 weeks of gestation. 
Thenceforth, PIVO2 decreases slowly, reaching values of 45–48 mmHg at 
36 weeks of gestation (9).
FiGURe 4 | Correlation between amniotic fluid levels of erythropoietin 
(ePO) and meta-tyrosine, a biomarker of oxidative damage to protein 
in diabetic type 2 pregnancies treated with insulin (23).
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normal early in pregnancy (8–14  weeks gestation) would be 
indicative of hypoxia in late pregnancy (>24  weeks gestation). 
Noteworthy, during the embryonic stage of development, the 
fetus is extremely sensitive to oxidative stress, and an environ-
ment of low oxygen is required for an adequate development. 
In the second half of pregnancy, the placenta will provide the 
fetus with higher amounts of oxygen and nutrients, allowing for 
an exponential increase in size and weight. Hence, studies per-
formed in human fetuses have shown that before the 12th week of 
gestation, the intervillous partial pressure of oxygen has a median 
value around 18–20 mmHg but rises steeply peaking at 60 mmHg 
around 14–16  weeks gestation, and thereafter decreases slowly 
reaching values of 45–48 mmHg at 36 weeks of gestation (20, 21).
Fetal Oxygen Sensing
Physiological systems are adapted to sense O2 needs not only to 
avoid excessive exposures to ROS but also to provide sufficient O2 
to allow normal cellular functioning. The most relevant oxygen 
sensing transcription factors are hypoxia-inducible factor (HIF), 
cAMP response-binding protein (CREB), nuclear factor kappa B 
(NFκB), activator protein 1 (AP-1), and p53. These factors regulate 
gene expression in response to changes in the concentration of 
oxygen and derived ROS. Low O2 containing environments favor 
early placental and fetal development. Angiogenesis is stimulated 
by low oxygen tissue concentrations through transcriptional and 
post-transcriptional regulation of growth factors, such as vascu-
lar endothelial growth factors (VEGFs), erythropoietin (EPO), 
placental growth factor (PGF), and angiopoietins 1 and 2. The 
master regulator for the cell’s adaptive responses to hypoxia is 
HIF-1, a heterodimeric transcription factor comprising HIF-1α 
and HIF-1β subunits (22). Activated genes, especially VEGF 
and EPO, enhance O2 delivery to tissue. EPO does not cross the 
placenta, and it does not accumulate in tissue. Therefore, fetal 
plasma concentration of EPO is determined by its rate of synthe-
sis and elimination, and amniotic fluid EPO levels correlate well 
to fetal and neonatal plasma EPO levels obtained simultaneously 
at elective and emergency cesarean section. Amniotic fluid EPO 
concentration increases exponentially during fetal hypoxia and 
correlates to oxidative and nitrosative stress in the fetus (Figure 4). 
Alteration of EPO concentration in amniotic fluid correlates to 
immediate postnatal complications and could, therefore, be used 
as a reliable biomarker to indicate emergency C section (23).
FeTAL TO NeONATAL TRANSiTiON AND 
POSTNATAL ADAPTATiON
Oxidative Stress in the Fetal to Neonatal 
Transition
Even with a mature AO system, the burden of ROS as a 
consequence of the fetal to neonatal transition renders oxida-
tive stress in the immediate postnatal period inevitable even 
breathing 21% oxygen. In an experimental study at different 
stages of development in rats, GSH/GSSG ratio decreased 15- to 
20-fold in isolated hepatocytes from fetal to neonatal and to 
adult animals due an exponential increase in GSSG indicating 
that a pro-oxidant status is generated in the fetal to neonatal 
transition (24). Gelfand et al. showed that the use of pure oxygen 
after a hypoxic episode in intubated and ventilated rat pups was 
able to significantly reduce the GSH/GSSG ratio causing an 
intense oxidative stress (25). In addition, Presti et  al. showed 
short- and long-term outcome differences between room air 
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and oxygen-resuscitated subjects were demonstrated in a P7/8 
murine model (26). In pups resuscitated with pure oxygen, 
cerebral blood flow was more rapidly restored, however, with 
worsened short-term sensorimotor deficit raising additional 
concerns regarding post-resuscitation hyperemia (26). Notably, 
in a very recent experimental study with an innovative design, 
offspring of pregnant mice were allowed to deliver in a low 
oxygen atmosphere mimicking in  utero milieu (FiO2 =  0.14). 
Pups were kept at this low FiO2 for 8  h. Biochemical analysis 
of lung tissue revealed an increased GSH/GSSG ratio in lung in 
day 1 and in the brain in day 7 after birth as compared to pups 
born in room air (FiO2 = 0.21). Interestingly, mRNA expression 
of NRF-2-related AO genes was significantly increased in lung 
and brain (27). Apparently, a smooth transition from the lower 
oxygen milieu in utero to the relatively hyperoxic milieu ex utero 
seemed to be protective. Translating these findings into the 
clinical setting would imply avoiding targeting high saturations 
too rapidly in preterm infants after birth.
The use of high concentrations of oxygen even for short 
periods of time has deleterious effects on the lung. Hence, free 
radicals cause an inflammatory response with destruction of the 
alveolar–capillary barrier, increased pulmonary permeability, 
and endothelial and epithelial cell death, leading to citoarchitec-
tural alterations and predisposition to chronic lung disease [for 
a review, see Ref. (28)]. Moreover, stabilization with high oxygen 
concentrations is not only toxic to the lungs but also to different 
organs such as heart, liver, and brain. Studies in a hypoxic piglet 
model of hypoxia-reoxygenation showed that the use of pure 
oxygen caused not only an increased concentration of extracel-
lular glycerol in the brain striatum but also increased matrix 
metalloproteinases in lung, liver, heart, and brain compared with 
the use of room air. Interestingly, there is clear dose-dependent 
oxygen toxicity, and elimination of biomarkers of oxidative dam-
age caused to protein and DNA significantly correlated to the 
FiO2 provided during resuscitation (29).
Circulatory Changes in the Fetal to 
Neonatal Transition
During fetal life, the gas exchange between mother and fetus 
is performed across the placenta. In the fetal circulation, most 
of the right ventricular output is directed through the ductus 
arteriosus to the aorta, and only 5–10% of the combined 
ventricular output is directed to the pulmonary vascular bed. 
Pulmonary vascular resistance increases with gestational age 
reaching values equivalent to systemic pressure. Vascular tone 
of the fetal lung is maintained by different pathways, which 
include high vasoconstriction agents, such as low oxygen 
tension, endothelin-1, leukotrienes, and Rho kinase, and low 
basal level of vasodilators, such as prostacyclin and nitric oxide 
(NO) (30). Abrupt changes in the pulmonary circulation occur 
immediately after cord clamping and the initiation of the first 
breaths. These are characterized by a rapid fall in the pulmo-
nary vascular resistance and pulmonary artery pressure, and a 
10-fold rise in pulmonary blood flow, which becomes the sole 
recipient of right ventricular output. Moreover, pulmonary 
blood flow represents few minutes after birth, the only source of 
preload for the left ventricle. The most critical signals for these 
transitional changes are mechanical distension of the lung, a 
decrease in carbon dioxide tension, and an increase in oxygen 
tension in the lungs. Altogether, these changes are triggered by 
the elimination of the fluid filling the lungs and subsequent lung 
aeration (31). In term infants, it takes only about few minutes 
to almost completely aerate the lung. It has been generally 
accepted that the principal mechanism by which lung liquid 
is cleared from the airways at birth is via adrenaline-induced 
sodium reabsorption, which reverses the osmotic gradient 
that drives liquid secretion across the pulmonary epithelium 
during fetal life. However, recent studies using phase contrast 
X-ray imaging techniques have shown that the transpulmonary 
hydrostatic pressure gradient generated with the first inspira-
tory movements provides the driving force that clears lung 
fluid into the interstitial tissue, where it is rapidly eliminated 
through the lymphatic or the macrophages. Remarkably, no 
liquid clearance from the airways has been detected during the 
expiratory phase. However, it is possible that transepithelial Na+ 
reabsorption plays a critical role in retaining liquid within the 
interstitial tissue compartment, thereby preventing its re-entry 
into the alveolar space during expiration (32). These findings 
have a direct translational application. Hence, a positive pres-
sure in the airway will decisively contribute to a rapid aeration 
of the lung and an efficient gas exchange. This can be elicited by 
a spontaneously breathing pattern in the health newborn or will 
need to be achieved, employing an adequate ventilation strategy 
by the resuscitation team that includes positive-end expiratory 
pressure. However, the use of a sustained inflation, although 
successful in experimental studies (33), has not shown to be 
provide substantial advantages for preterm infants in the clinical 
setting. In a randomized controlled multicenter trial performed 
in Italy, preterm infants <29 weeks gestation were administered 
an initial sustained lung inflation of 25 cmH2O for 15 s followed 
by nCPAP or nCPAP alone. The primary outcome, which was the 
need for mechanical ventilation in the first 72 h after birth, was 
significantly lower in the sustained inflation group. However, 
no differences regarding the need for respiratory support or 
survival without BPD were shown. Moreover, an increase in the 
incidence of pneumothorax was present in the sustained lung 
inflation group (34). Notwithstanding, an ongoing multicenter 
international randomized controlled trial adequately powered, 
which includes spontaneously breathing preterm babies of 
23–26 weeks gestation receiving an initial sustained inflation of 
25 cmH2O for 15 s in the delivery room, aims to reduce BPD or 
death at 36 weeks postmenstrual age (35).
Oxygen content of the inspiratory gas admixture decisively 
influences lung vascular tone and is considered one of the main 
factors causing vasodilatation in the fetal to neonatal transition 
(36). Traditionally, high oxygen inspiratory fractions have been 
recommended to enhance newly born infants postnatal adapta-
tion, especially in asphyxiated term babies but also in preterm. 
However, experimental and clinical studies have shown that 
fetal to neonatal transition and oxygen supplementation cause 
an increased production of oxygen free radicals, especially anion 
superoxide (37). Under normal circumstances, exposure to a 
brief period of hyperoxia triggers the expression of SODs, which 
FiGURe 5 | (A) Under normal circumstances, nitric oxide produced by the 
action of NO synthase activates guanylate cyclase, which catalyzes the 
formation of cGMP and subsequently lung vessel vasodilatation. In addition, 
superoxide anion, derived from air-borne oxygen by the action of superoxide 
dismutases, is catalyzed to hydrogen peroxide, which acts also as lung 
vessel vasodilator. (B) In the presence of oxygen in excess (resuscitation and 
ventilation), anion superoxide will sequester nitric oxide and produce highly 
reactive peroxynitrite. The amount of available cGMP is reduced and also the 
production of hydrogen peroxide. Under these circumstances, there is a 
potent tendency toward vasoconstriction (17, 25, 27).
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dismutate anion superoxide to hydrogen peroxide (Figure  5). 
H2O2 has a vasodilatation effect upon the lung vasculature, 
thus reducing vascular resistance and increasing pulmonary 
blood flow. However, in the presence of an excess of oxygen, 
non-dismutated anion superoxide may cause vasoconstric-
tion by reducing the bioavailability of nitric oxide through 
the blocking the activity of eNOS and favoring the formation 
of the highly toxic peroxynitrite; moreover, in smooth muscle 
cells, free radicals inactivate soluble guanyl cyclase and activate 
phosphodiesterase P5, resulting in decreased levels of cyclic 
guanidine monophosphate. Altogether, these mechanisms lead 
to pulmonary vasoconstriction (Figure 5) (38, 39).
OXYGeNATiON BeFORe AND AFTeR 
BiRTH
Alveolar–capillary gas exchange requires lung fluid resorption, 
lung expansion, and the establishment of a functional residual 
capacity before reaching a stable arterial partial pressure of oxygen 
(paO2). In a term newborn infant, several minutes are needed after 
spontaneous breathing is initiated to complete this process. The 
evaluation of the metabolic and oxygenation status of the fetus 
and its correlation with immediate postnatal adaptation has been 
attempted using different approaches. Experimental studies in 
sheep models have shown that there is a good correlation between 
fetal scalp and preductal paO2; however, there are physiological 
artifacts in the technique itself, such as aerobic contamination 
that may cause inaccurate results. Fetal pulse oximetry (FSpO2) 
in sheep has revealed that oxygen saturation before birth in the 
term fetus is stable around 50–70%. However, there is a “critical 
threshold” with FSpO2 <30% for more than 5–10 min. Prolonged 
low FSpO2 has been associated with low fetal arterial pH and lac-
tic acid content (40). However, observational clinical studies have 
shown that both scalp pH and fetal pulse oximetry monitoring 
have not provided conclusive results and have not reduced the 
rate of cesarean section (41, 42).
After birth, the rate at which fetal SpO2 changes into newborn 
values is more gradual than previously believed. Newborn SpO2 
levels do not reach stable values >90% until 5–15 min after birth 
elapse. This collides with the validity of pink color as one of the 
items valuated in the 1-min Apgar score. Based only on clini-
cal inspection, there is a great variability in assessing newborn’s 
peripheral or even central color. Pulse oximetry has provided 
delivery room caregivers with an objective measurement of 
infant’s saturation and heart rate, which allows taking therapeutic 
initiatives as to how to stabilize each individual patient. Therefore, 
the use of pulse oximetry in the delivery room, especially for 
stabilization of preterm infants, is warranted (43, 44). However, in 
the recent ILCOR 2015 guidelines, there is a weak recommenda-
tion to use when available EKG instead of pulse oximetry to assess 
heart rate in the delivery room. EKG is meant to be more rapid 
and accurate; however, the evidence is indirect and imprecise, 
and therefore, this recommendation is considered weak and of 
very low quality (45).
The preliminary information regarding evolving SpO2 in 
the fetal to neonatal transition has been summarized by Finer 
and Leone in a recent review (46). In healthy term babies, pulse 
oximetry values retrieved in different observational studies were 
≈60% at 1 min, 70% at 2min, 82% at 5 min, and 90% at 10 min. 
Moreover, pre- and postductal values differed in ~5–10% dur-
ing the first minutes of life, and babies born by C-section had 
lower SpO2 values and needed longer time to achieve stable SpO2 
>85% (46).
Dawson et al. developed an arterial oxygen saturation nomo-
gram, aggregating three data sets from the Royal Women Hospital 
(Melbourne) and University and Polytechnic Hospital La Fe 
(Valencia). Data sets included preductal SpO2 retrieved every 
2 s in healthy term and preterm infants during the first minutes 
after birth. Thereafter, data were mathematically treated to put up 
centile curves (47). Eligible infants had not received any interven-
tion during stabilization period, such as supplemental oxygen or 
positive pressure ventilation, or had any congenital anomaly that 
could alter postnatal oxygenation. Of the total number of babies, 
8% were preterm <32 weeks gestation, 26% 32–34 weeks gesta-
tion, and 66% term. The median to attain reliable SpO2 readings 
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was 65  s (IC 5–95%: 58–85  s). Of note, there were significant 
differences between term and preterm infants along the first 
minutes after birth. Hence, while the median of term infants 
reached SpO2 >85% at 4 min after birth, preterm infants needed 
7–8 min. Moreover, 10 min after birth, term babies were stable 
at 97% SpO2 and preterm at 94% (p < 0.001). In addition, babies 
born by vaginal delivery achieved stable saturations around 90% 
at 4–5 min, while babies born by C-section needed 6 min (47). 
There is an inverse correlation between gestational age and time 
to achieve stable SpO2 >85%, and therefore, the mort preterm 
infants will need longer time before they acquire a stable oxygena-
tion level. Achievement of a SpO2 plateau after birth apparently 
correlates to time to eliminate fluid from the respiratory airways, 
recruit alveoli and expand the lung, and establish a functional 
residual capacity during expiration.
iNiTiAL FiO2 iN PReTeRM iNFANTS
The 2015 ILCOR guidelines recommend that preterm infants 
should be initially stabilized using 0.21–0.30 oxygen inspira-
tory fraction (FiO2), aiming to avoid hyper- or hypoxemia (45). 
Studies performed in the last decade have shown that the use 
of 0.21 as initial FiO2 was insufficient to overcome hypoxemia 
and bradycardia in the first minutes after birth, while the 
use of higher oxygen concentrations (FiO2 =  0.9–1.0) caused 
hyperoxemia and oxidative stress. Wang et  al. compared the 
use of 0.21 versus 1.0 as initial FiO2 in preterm infants with 
gestational age ≤28  weeks gestation. After 2  min, 30% of the 
patients were switched to 1.0 FiO2 because of persistent brady-
cardia, and at 3 min, the remaining 60% needed also an FiO2 
of 1.0 because they did not achieve targeted SpO2 of 70% at 
3  min (48). Remarkably, Vento et  al. showed that the use of 
high initial FiO2’s of 0.90 caused hyperoxemia, oxidative stress, 
and an increased incidence of bronchopulmonary dysplasia 
(49). Kapadia et al. (50) randomized preterm infants into two 
different strategies. A group received an initial FiO2 of 1.0 and 
the other 0.21, and both were titrated according to SpO2 read-
ings to achieve pre-established oxygenation targets. Results 
were coincidental with the study by Vento et  al. (49). Hence, 
this study found an increased oxidative stress in the first hours 
after birth, more need of oxygen, more days on mechanical 
ventilation, and more BPD defined as the need for oxygen at 
36  weeks postmenstrual age in the group that received 100% 
oxygen as initial gas admixture (50). In the interim, intermedi-
ate inspiratory fractions ranging from 0.3 to 0.5 have become 
generalized without strong evidence-based support. In a recent 
updated review and meta-analysis, 10 randomized studies 
including 321 infants who had received low (0.21–0.30) and 
356 who received high (0.60–1.0) initial FiO2 were compared 
for relevant outcomes, such as mortality, bronchopulmonary 
dysplasia, and intraventricular hemorrhage (51). Of note, 
results from these meta-analysis showed that babies initially 
resuscitated with lower FiO2 approached almost significance for 
the outcome of reduced mortality [0.62 (95% CI: 0.37–1.04)]. 
Furthermore, there was no significant association for bron-
chopulmonary dysplasia or intraventricular hemorrhage when 
comparing low and high FiO2 (51). This information has been 
questioned by recent reports from two studies performed in 
Australia and Canada, respectively. Oei et al. (52) at the 2015 
Pediatric Academic Societies Annual Meeting (USA) presented 
results of a large randomized controlled study completed to 
date, which examined the effects of resuscitation with an initial 
FiO2 of 0.21 versus 1.0 in 289 preterm infants <32 weeks gesta-
tion. Target SpO2 was set at 65–95% up to 5 min and 85–95% 
until admission to the NICU. The most relevant finding was a 
mortality of 16.2% in the subgroup of babies <29 weeks gesta-
tion in the 0.21 group versus 6% in the 1.0 group (RR = 3.18; 
1.41–7.19; p  =  0.013). This difference, although statistically 
marginal, emphasized the urgent need for larger randomized 
controlled trials to examine this question (52). Recently, the 
Canadian Neonatal Network published a retrospective cohort 
study comparing infant’s ≤27 weeks gestation before and after 
2006 when the policy regarding initial FiO2 for preterm in 
the DR was changed from 100 to <100% oxygen and titration 
according to SpO2 (53). Adjusted OR (AOR) for the primary 
outcome of severe neurologic injury or death was higher in 
the lower oxygen group (AOR 1.36; 95% CI: 1.11–1.66) and 
in those resuscitated with RA (AOR 1.33; 95% CI: 1.04–1.69), 
when compared with 100% oxygen. Of note, researchers did not 
have data about oxygen exposure for each individual infant, and 
therefore, it could be misleading to attribute specific outcomes 
to the initial FiO2 used at delivery. However, the investigators 
cautioned that a policy of initial stabilization with lower oxygen 
could be linked to a higher risk of severe neurologic injury or 
death in very preterm infants compared to starting with 100% 
oxygen (53).
To define the best practice for the initial oxygen concentra-
tion for the transition and resuscitation of the very preterm 
infant requires the completion of additional well-designed and 
adequately powered randomized trials, such as the PRESOX 
(ClinicalTrials.gov Identifier: NCT01773746), and the Torpido 
2 study that aims to examine outcomes of babies below 
29 weeks gestation after initiation of resuscitation with either 
FiO2 0.21 or 0.6. Hopefully, in the coming years, when both 
these studies are completed, we will have an answer to these 
burning questions.
CONCLUSiON
Oxygen is the most widely employed drug in Neonatology. 
Prematurity is associated with an immature respiratory and AO 
defense systems. Therefore, preterm infants frequently need oxygen 
supplementation to effectively transit from fetal to neonatal envi-
ronment but develop oxygen free radical-associated conditions.
In recent years, experimental and clinical research studies 
have aimed to define the best approach to avoid damage caused 
by hyper- or hypoxia. Pursuing this objective a nomogram for 
oxygen saturation in the first minutes of life has been developed. 
Adjusting FiO2 to keep babies within the normality range has been 
proposed. However, there are still many unanswered questions: (i) 
which is the best starting FiO2? (ii) which is the best monitoring 
and titration practice to avoid hyper-or-hypoxia? (iii) which are 
the most appropriate SpO2 targets for very preterm infants? (iv) 
should all gestational ages be approached with the same initial 
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FiO2? and (v) what should be done until the first reliable SpO2 
reading is available?
Completion of two randomized controlled multicenter trials 
will hopefully provide us with the clues for an optimal use of 
oxygen in the fetal to neonatal transition.
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